First clinical genome analysis funding from Genomics England

5 May 2014

A Cambridge-based company has been awarded funding by Genomics England for development of a platform for clinical genome analysis.
 
Congenica Ltd, a clinical genomics company, will further develop the SAPIENTIA platform created using technology originally developed by (and licensed from) the Wellcome Trust Sanger Institute, which led the UK arm of the international human genome project and remains the preminent UK genome sequencing and analysis centre. The SAPIENTA platform is said to offer a ‘scalable data analytics pipeline for the annotation and clinical interpretation of genomic sequence data’ suitable for research or clinical application.
 
The £200,000 funding is from a Small Business Research Initiative (SRBI) competition worth up to a total of £10 million provided by the UK Department of Health and managed by Genomics England. Other winning companies have yet to announce receipt of funding.

Congenica’s CEO Dr Tom Weaver said the award was: “a measure of how critical the analysis tools we are developing will be for supporting national scale screening projects” including the 100,000 Genomes Project.

 

More from us

Genomics and policy news